Rondonotti Emanuele, Soncini Marco, Girelli Carlo M, Russo Antonio, de Franchis Roberto
aGastroenterology Unit, Valduce Hospital, ComobGastroenterology Unit, S. Carlo Borromeo HospitalcASL Milan 1, Region LombardiadUniversity of Milan, MilaneDepartment of Internal Medicine, Busto Arsizio Hospital, Busto Arsizio, Italy.
Eur J Gastroenterol Hepatol. 2016 Aug;28(8):871-5. doi: 10.1097/MEG.0000000000000628.
Both Agile patency capsule (PC) and small-bowel cross-sectional imaging (SBCSI) techniques have been used to assess small-bowel patency in patients at high risk of capsule retention. The present study aimed to compare capsule retention rates in high-risk patients with negative PC or SBCSI.
Between January 2011 and December 2013, consecutive patients undergoing small-bowel capsule endoscopy (SBCE) in the Lombardia region were prospectively entered into a dedicated registry. They were classified as being at high or low risk of capsule retention by the local investigator according to predefined clinical criteria. High-risk patients underwent either PC or SBCSI depending on local expertise and availability; those who tested negative underwent SBCE.
Out of 3117 patients (male/female: 1667/1450, mean age: 63.1±17.7), 2942 (94.4%) were classified as being at low risk and 175 (5.6%) were classified as being at high risk for capsule retention. Among 175 high-risk patients, 151 (86.3%) had negative PC and 24 (13.7%) had negative SBCSI: capsule retention occurred in two patients with negative SBCSI (8.3%) and in one patient (0.7%) with negative PC (P=0.049). The capsule retention rates in high-risk patients with negative PC and in low-risk patients (20/2942; 0.7%) were comparable (P=1.0).
The capsule retention rate is similar in low-risk and negative PC high-risk patients. Conversely, high-risk patients with negative SBCSI have a significantly higher capsule retention rate. Our data suggest that in high-risk patients, negative SBCSI examination is not reassuring and, when SBCE is indicated, PC should be performed.
敏捷通畅胶囊(PC)和小肠横断面成像(SBCSI)技术均已用于评估有胶囊滞留高风险患者的小肠通畅情况。本研究旨在比较PC或SBCSI结果为阴性的高风险患者的胶囊滞留率。
2011年1月至2013年12月期间,在伦巴第地区接受小肠胶囊内镜检查(SBCE)的连续患者被前瞻性纳入一个专门的登记系统。当地研究人员根据预先定义的临床标准将他们分类为有高或低胶囊滞留风险。高风险患者根据当地的专业知识和可获得性接受PC或SBCSI检查;检查结果为阴性的患者接受SBCE。
在3117例患者中(男/女:1667/1450,平均年龄:63.1±17.7),2942例(94.4%)被分类为低风险,175例(5.6%)被分类为有高胶囊滞留风险。在175例高风险患者中,151例(86.3%)PC结果为阴性,24例(13.7%)SBCSI结果为阴性:2例SBCSI结果为阴性的患者(8.3%)和1例PC结果为阴性的患者(0.7%)发生了胶囊滞留(P=0.049)。PC结果为阴性的高风险患者和低风险患者的胶囊滞留率(20/2942;0.7%)相当(P=1.0)。
低风险和PC结果为阴性的高风险患者的胶囊滞留率相似。相反,SBCSI结果为阴性的高风险患者的胶囊滞留率显著更高。我们的数据表明,在高风险患者中,SBCSI检查结果为阴性并不令人放心,当需要进行SBCE时,应进行PC检查。